Parallel Advisors, LLC Alx Oncology Holdings Inc Transaction History

Parallel Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$10.95 - $16.79 $1,368 - $2,098	-125 Reduced 37.99%	204 $2,000
Q3 2023 May 20, 2024	BUY	$4.19 - $7.35 $523 - $918	125 Added 61.27%	329 $1,000
Q3 2023 Nov 13, 2023	BUY	$4.19 - $7.35 $1,378 - $2,418	329 New	329 $1,000
Q1 2022 Apr 28, 2022	SELL	$13.65 - $22.06 $0 - $0	0 Closed	0 $0
Q4 2021 Jan 20, 2022	SELL	$21.49 - $74.4 $1,848 - $6,398	-86 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$52.51 - $80.91 $4,515 - $6,958	86 New	86 $6,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $68.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.